We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Buys

Rank Stock Value
1
QRVO icon
Qorvo
QRVO
+$153M
2
ASML icon
ASML
ASML
+$117M
3
RVMD icon
Revolution Medicines
RVMD
+$58.1M
4
META icon
Meta Platforms (Facebook)
META
+$49.6M
5
ISRG icon
Intuitive Surgical
ISRG
+$48.5M

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TYRA icon
326
Tyra Biosciences
TYRA
$1.75B
$3.73M 0.05%
264,745
-101,290
-28% -$2.01M
PRVA icon
327
Privia Health
PRVA
$2.98B
$3.7M 0.05%
142,850
-66,825
-32% -$1.67M
STFC
328
DELISTED
State Auto Financial Corp
STFC
$3.61M 0.05%
69,839
+33,213
+91% +$1.71M
UAA icon
329
Under Armour
UAA
$2.9B
$3.58M 0.05%
+168,842
New +$3.83M
SMIH
330
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
$3.56M 0.05%
367,600
– –
QTTB icon
331
Q32 Bio
QTTB
$489M
$3.52M 0.05%
+53,726
New +$5.21M
SDGR icon
332
Schrodinger
SDGR
$1.17B
$3.51M 0.05%
+100,670
New +$4.6M
ATEK.U
333
DELISTED
Athena Technology Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-half of one Redeemable Warrant
ATEK.U
$3.49M 0.05%
+350,000
New +$3.49M
AMCX icon
334
AMC Global Media
AMCX
$499M
$3.47M 0.05%
+100,841
New +$4.2M
ARTA
335
DELISTED
Artisan Acquisition Corp. Class A Ordinary Shares
ARTA
$3.47M 0.05%
350,000
– –
ELDN icon
336
Eledon Pharmaceuticals
ELDN
$270M
$3.45M 0.05%
781,376
– –
VAQC
337
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$3.42M 0.05%
350,000
– –
LGAC
338
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$3.41M 0.05%
350,000
– –
ZLS
339
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$3.4M 0.05%
+354,215
New +$3.43M
ESM
340
DELISTED
ESM Acquisition Corporation
ESM
$3.4M 0.05%
350,000
– –
SDST
341
Stardust Power Inc
SDST
$6.77M
$3.4M 0.05%
35,000
– –
FRON
342
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$3.4M 0.05%
350,000
– –
IPSC icon
343
Century Therapeutics
IPSC
$363M
$3.3M 0.05%
208,082
-42,012
-17% -$789K
SPRY icon
344
ARS Pharmaceuticals
SPRY
$524M
$3.29M 0.05%
493,895
+68,634
+16% +$558K
SLCR
345
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$3.28M 0.05%
334,709
– –
ABOS icon
346
Acumen Pharmaceuticals
ABOS
$164M
$3.25M 0.05%
480,681
+11,887
+3% +$131K
LGV
347
DELISTED
Longview Acquisition Corp. II
LGV
$3.2M 0.05%
325,000
– –
PEGRU
348
DELISTED
Project Energy Reimagined Acquisition Corp. Unit
PEGRU
$3.19M 0.05%
+300,000
New +$2.99M
THRX
349
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$3.17M 0.05%
+250,000
New +$3.77M
FSNB
350
DELISTED
Fusion Acquisition Corp. II
FSNB
$3.15M 0.05%
324,992
– –
12 13
14
15 16

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.